DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Plant-based alternatives: Why brands can win with new flavor innovation
Many consumers feel plant-based foods lack taste variety amid low product launch activity in flavors.
Gen Z pushes for bolder, authentic, and globally inspired flavors, while health-conscious consumers want functional flavors that combine taste with wellness.
Companies like Symrise use proprietary technologies and AI to overcome plant protein taste challenges, enhance flavor complexity, and forecast future flavor trends.
Joint Research for Developing Biomarkers of Depression and Stress in Children and Youth
Rhelixa Inc. (President and CEO: Ryu Nakagi, hereinafter “Rhelixa”) and the Department of Psychiatry, Graduate School of Medicine, Kobe University (Principal Investigator: Professor Akiyasu Hishimoto, hereinafter “Kobe University”) have commenced a joint research project aimed at developing a DNA methylation biomarker for non-invasively assessing depressive and stress states in children and adolescents. Our company will advance research and development toward societal implementation using part of the research outcomes generated under Goal 9 of the “Moonshot R&D Program.”
New Release: "Polyamine Increasing Supplement"
Kyodo Milk Industry Co., Ltd. will launch "Polyamine Increasing Supplement" on January 19, 2026, which increases polyamine, a substance essential for healthy cell activity, in the gut. This supplement utilizes a proprietary technology that stably promotes polyamine production in the intestines by co-ingesting Bifidobacterium LKM512 and arginine. It aims to compensate for the age-related decline in polyamine production and ensure a stable supply of polyamine, a component attracting global research interest for its links to health maintenance and aging. The allergen-free, easy-to-take granule form allows for convenient daily condition support.
AI on the Pulse: Real-Time Health Anomaly Detection with Wearable and Ambient Intelligence
"AI on the Pulse" is a real-time anomaly detection system that continuously monitors patients using a fusion of wearable sensors, ambient intelligence, and advanced AI models. Powered by the state-of-the-art UniTS universal time-series model, it autonomously learns unique physiological and behavioral patterns to detect subtle health deviations. Unlike traditional classification, it provides personalized alerts for reactive home-care interventions. The system demonstrates robustness across medical devices and consumer wearables, outperforming 12 existing methods by approximately 22% in F1 score. It enables high-quality health monitoring with non-invasive devices like smartwatches and enhances interpretability by integrating LLMs to translate anomaly scores into clinical insights.
Preparing for the Risk of “RNA Degradation” in mRNA Manufacturing Processes—Launching GMP-Grade RNase Inhibitors
Takara Bio launched its “Recombinant RNase Inhibitor GMP grade” on November 18, 2025, to ensure the quality of RNA handled in the manufacturing processes of RNA therapeutics, including mRNA vaccines.
This product is a GMP-grade version based on the company's “Recombinant RNase Inhibitor ver.2.0” used in its basic research. It maintains equivalent performance to conventional RNase inhibitors derived from human or porcine tissues while achieving high oxidative stability through mutations that suppress enzyme inactivation. RNA molecules, gaining attention in novel modality fields, demand stringent quality control from their manufacturing processes. This product is designed to meet these requirements.
Manufactured in a GMP-controlled facility compliant with ICH Q7 and PIC/S, this product has passed impurity tests for endotoxins, contaminating microorganisms, and process-derived nucleic acids/proteins, ensuring safety. Neither human/animal-derived materials nor β-lactam compounds are used in primary raw materials or the final formulation. Various nuclease assays have also verified the absence of nucleic acid degradation activity.
Takara Bio offers a broad range of enzymes and synthesis kits for mRNA synthesis; this marks its fourth GMP-grade product. mRNA vaccine development is expanding globally, with multiple national projects underway in Japan. The company aims to further strengthen its foundation supporting mRNA therapeutics—from R&D to manufacturing—by integrating this offering with its CDMO business, which handles contract manufacturing for mRNA therapeutics (including mRNA vaccines).
Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
AptarGroup, Inc. has unveiled its expanded portfolio of eye care solutions, featuring the new "Beat the Blink™" technology. This innovative delivery system is designed to improve dosing precision and enhance patient experience by overcoming the blink reflex. Developed in an exclusive partnership with Bausch and Lomb, it offers horizontal drop delivery and protection for preservative-free formulations, addressing critical needs in ophthalmic treatment and aiming for high-quality eye care delivery.
Canon Medical Secures FDA Clearance for Ultrasound Innovations, Advancing Image Clarity and Workflow Efficiency
Canon Medical Systems USA, Inc. has received FDA 510(k) clearance for its Aplio i-series diagnostic ultrasound systems with Software Version 9.0. This new release features three key innovations: 3rd Harmonic Imaging (3-HI) for improved image quality using deep learning AI, SMI Angio for clearer microvascular flow visualization, and Auto Tune Shear Wave for automated settings and accurate elasticity measurements. These advancements aim to enhance diagnostic confidence and workflow efficiency, supporting clinicians in delivering high-quality care.
Successful Hydrogen Production at Ammonia Cracking Pilot Plant Using Steam Heating Method
三菱重工業は、独自のアンモニア分解システム（注1）の開発に関して、当社総合研究所長崎地区に設置したパイロットプラントにおいて、このたび、蒸気を加熱源として利用することによって、原料のアンモニアを分解し、純度99％の水素を製造することに成功しました。蒸気加熱方式によるパイロットスケールでの水素製造は世界で初めて（注2）となります。
当社の蒸気・排ガス加熱方式は、バーナー燃焼熱を用いる従来の技術に比べ、低い反応温度でのシステムの運転を可能にするため、運転コストを削減できます。加えて、燃焼炉が不要なため、システムの小型化を実現できるなど、優れた特徴を有しています。
脱炭素社会の実現に向け、燃焼してもCO2を排出しない燃料である水素の利活用は、世界的に拡大しています。中でもアンモニアは、水素を安全かつ大量に長距離輸送・貯蔵できる「水素キャリア」として注目されています。
当社は、今回の成果を生かし、アンモニアを水素キャリアとする水素サプライチェーンの構築に向け、水素需要地の近くに設置可能な中規模・分散型アンモニア分解システムの開発を推進します。また、このパイロット試験の結果を踏まえ、国立研究開発法人新エネルギー・産業技術総合開発機構（NEDO）に採択された事業（注3）における開発を、株式会社日本触媒、北海道電力株式会社と協同で加速します。これらによって、脱炭素技術の早期確立・社会実装を図るとともに、持続可能なカーボンニュートラル社会の実現に貢献していきます。
TheWell Bioscience and PeptiGrowth Enter into Marketing Collaboration Agreement to Advance Next-Generation Cell Culture Solutions
TheWell Bioscience, a pioneer in animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in synthetic peptide growth factors, have formed a marketing collaboration. This partnership aims to advance next-generation cell culture solutions for stem cell culture, organoid development, and cell therapy manufacturing. By combining TheWell Bioscience's VitroGel® hydrogel system and xeno-free RocketCell™ media with PeptiGrowth's chemically synthesized, animal-component-free peptide growth factors, they offer a complete xeno-free workflow. This collaboration seeks to expand the adoption of their complementary platforms globally, addressing critical challenges in regenerative medicine and cell therapy research by providing safe, scalable and consistent biomaterials.
Siemens Healthineers Experience Center USA opens in Charlotte’s Innovation District, Featuring the Latest in Healthcare Technology
Siemens Healthineers has launched its first United States-based Experience Center at The Pearl, Advocate Health’s innovation district in Charlotte, North Carolina. The district brings together the city’s first four-year medical school, the Charlotte campus of Wake Forest University School of Medicine; IRCAD North America, a center for advanced surgical training; and several of the most innovative healthcare technology companies. Spanning 60,000 square feet, the Siemens Healthineers Experience Center USA features the latest technologies in imaging, diagnostics, cancer care, and advanced therapies.
Designed as an immersive, hands-on environment, the facility will enable healthcare professionals, industry leaders, and strategic partners to engage and collaborate on today’s most pressing healthcare needs. As an element of its partnership with IRCAD North America, Siemens Healthineers will provide medical imaging technology and support curriculum development for the surgeons and the teams who train at their new facility.
A novel approach leveraging the hair component “cysteine” Establishing a new technology that simultaneously repairs hair and enables hair coloring
Hoyu Co., Ltd. (Headquarters: Nagoya City, Aichi Prefecture) announced it has established a new technology applying hair repair techniques to hair colorants by focusing on the amino acid “cysteine,” a key component of hair. Cysteine is abundant in keratin protein and is a vital component supporting hair strength and elasticity. Previous research has also demonstrated its high hair repair efficacy. However, its tendency to undergo chemical reactions has made stable incorporation into conventional hair color formulations difficult.
Hoyu has now developed a unique method to mix cysteine with the hair color agent immediately before application. This successfully enables efficient penetration of cysteine into the hair shaft. Verification results confirm improved shine and transparency, along with enhanced hair hydrophobicity and repair of internal cavities.
This technology leverages cystine's property of precipitating under acidic conditions, further enhancing the repair effect through an acidic post-treatment after coloring. This demonstrates the potential to achieve beautiful results while minimizing damage associated with coloring treatments.
The development lead stated, “We aim to deliver value to end-users by minimizing damage while providing long-lasting enjoyment, and to stylists by enabling trend-setting designs while maintaining beautiful hair. By identifying the needs of both the salon environment and users, we will continue pursuing fundamentally valuable ingredients and technologies.”
Scientists reveal a tiny brain chip that streams thoughts in real time
BISC is an ultra-thin neural implant that creates a high-bandwidth wireless link between the brain and computers. Its tiny single-chip design packs tens of thousands of electrodes and supports advanced AI models for decoding movement, perception, and intent. Initial clinical work shows it can be inserted through a small opening in the skull and remain stable while capturing detailed neural activity. The technology could reshape treatments for epilepsy, paralysis, and blindness.
Commercial 5G Enables Stable Wireless Remote Control of “Robot That Conveys the Feel of Touching Objects”
NTT DOCOMO, Inc. (hereinafter DOCOMO) and the Keio University Haptics Research Center (hereinafter Keio) have combined Keio's developed robotics technology “Real Haptics®” developed by Keio University. By combining this technology with network latency mitigation functions installed on MEC and Docomo's commercial 5G mobile data communication, they have achieved stable wireless remote operation of a robot capable of conveying the tactile feedback felt when touching objects requiring delicate force control. This marks the first successful implementation of this technology in Japan. This proof-of-concept (hereinafter referred to as this proof-of-concept) is Japan's first initiative realized by equipping docomo MEC with network latency countermeasures developed by docomo.